Cargando…
Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects
Diabetic retinopathy is a highly specific microvascular complication of diabetes and a leading cause of blindness worldwide. It is triggered by hyperglycemia which causes increased oxidative stress leading to an adaptive inflammatory assault to the neuroretinal tissue and microvasculature. Prolonged...
Autores principales: | Saxena, Rohit, Singh, Digvijay, Saklani, Ravi, Gupta, Suresh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398738/ https://www.ncbi.nlm.nih.gov/pubmed/28539797 http://dx.doi.org/10.2147/EB.S69185 |
Ejemplares similares
-
Molecular Basis of Obesity: Current Status and Future Prospects
por: Choquet, Hélène, et al.
Publicado: (2011) -
Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects
por: Pilla, Lorenzo, et al.
Publicado: (2020) -
Telemedicine in Diabetic Retinopathy: Current Status and Future Directions
por: Das, Taraprasad, et al.
Publicado: (2015) -
Recent Advances in Syndactyly: Basis, Current Status and Future Perspectives
por: Zaib, Tahir, et al.
Publicado: (2022) -
Metabolism and Vascular Retinopathies: Current Perspectives and Future Directions
por: Singh, Charandeep
Publicado: (2022)